Litcius/Paper detail

Covid-19: UK becomes first country to authorise antiviral molnupiravir

Elisabeth Mahase

2021BMJ70 citationsDOI

Abstract

Covid-19: UK becomes first country to authorise antiviral molnupiravir

Topics & Concepts

InterimCoronavirus disease 2019 (COVID-19)AuthorizationAgency (philosophy)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)BusinessHealth care2019-20 coronavirus outbreakDrug treatmentPolitical sciencePublic administrationMedicineVirologyLawDiseaseInternal medicineOutbreakComputer scienceEpistemologyInfectious disease (medical specialty)PhilosophyComputer securityHealthcare Systems and ChallengesCOVID-19 Clinical Research Studies
Covid-19: UK becomes first country to authorise antiviral molnupiravir | Litcius